23 October 2017
News and Views
Links and Services
January's Alimentary Pharmacology & Therapeutics explored the mechanisms of action of rifaximin that may underlie its clinical benefits in travellers’ diarrhea.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors